Skip to main content

You have 2 new alerts

Show / Hide Alerts

Subaward Reporting is live on SAM.gov

Show Details Mar 8, 2025

As of March 8th 2025, FSRS.gov has retired, and users should complete all subaward reporting in SAM.gov now.

Find about the transition at SAM.gov/FSRS.
Find more about managing and searching subawards at Subaward Reports.
Find more about managing and searching subcontracts at Subcontract Reports.

Scheduled SAM Maintenance

Show Details Apr 22, 2025

SAM.gov will undergo planned maintenance on Saturday, May 10, 2025 from 8:00 AM to 1:00 PM EST. Users in SAM.gov will be unable to complete Entity Registrations and Exclusions during this window. Thank you for your understanding.

Contract Opportunity
Award Notices

Peramivir (RAPIVAB (peramivir injection)

Contract Award Date: Sep 25, 2024
Contract Award Number: 36F79721D0166
Task/Delivery Order Number: 75A50324F80012

Contractor Awarded Unique Entity ID: MGXADJ6SCLJ5

Contractor Awarded Name: BIOCRYST PHARMACEUTICALS INC
Contractor Awarded Address: Durham, NC 27703 USA
Base and All Options Value (Total Contract Value): $69,388,368.75

Contract Opportunity Type: Award Notice (Original)
Original Published Date: Sep 25, 2024 01:22 pm EDT
Inactive Policy: 15 days after contract award date
Original Inactive Date: Oct 10, 2024
Initiative:
- None

Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code:
- 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance:
Durham , NC 27703
USA

This requirement is for the supply of Peramivir (RAPIVAB (peramivir injection) 200mg/20ml vial (10mg/ml inj soln).

2945 FLOWERS ROAD
Atlanta , GA 30341
USA

Terri Reed
terri.reed@hhs.gov

Oct 25, 2024 11:55 pm EDTJustification (Original)
Oct 10, 2024 11:55 pm EDTAward Notice (Original)